Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.01B
sum of reported positions
Reported positions
489
Changes vs prior quarter
492
132 new · 79 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 155 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.45M | $691M | 8.6% | |
TEVA PHARMACEUTICAL INDS LTD | 12.5M | $412M | 5.1% |
| 1.37M | $397M | 5.0% | |
| 1.1M | $394M | 4.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.52B | $8.01B |
| Positions | 436 | 489 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 9% |
| 1.95M |
| $391M |
| 4.9% |
| 1.63M | $389M | 4.9% |
| 484K | $367M | 4.6% |
| 3.91M | $345M | 4.3% |
| 1.94M | $228M | 2.8% |
| 590K | $209M | 2.6% |
| 1.17M | $171M | 2.1% |
| 1.8M | $164M | 2.1% |
| 2.24M | $161M | 2.0% |
| 390K | $155M | 1.9% |
| 2.65M | $151M | 1.9% |
| 519K | $146M | 1.8% |
| 757K | $140M | 1.7% |
| 1.63M | $135M | 1.7% |
| 1.34M | $128M | 1.6% |
| 1.41M | $123M | 1.5% |
| 1.14M | $121M | 1.5% |
| 24M | $120M | 1.5% |
| 360K | $118M | 1.5% |
| 667K | $113M | 1.4% |
| 610K | $99.8M | 1.2% |
Target (TGT)
364 shares in Q1 2026
ISHARES SILVER TR · CALL
360 shares in Q1 2026
INVESCO QQQ TR · CALL
355 shares in Q1 2026
Post Holdings (POST)
332 shares in Q1 2026
Penske Automotive Group (PAG)
203 shares in Q1 2026
Gentex (GNTX)
186 shares in Q1 2026
Nexstar Media Group (NXST)
174 shares in Q1 2026
Laureate Education, Inc. (LAUR)
131 shares in Q1 2026
Enerpac Tool Group (EPAC)
108 shares in Q1 2026
SPDR S&P 500 ETF TR · CALL
100 shares in Q1 2026
Yeti Holdings (YETI)
100 shares in Q1 2026
Napco Security Technologies (NSSC)
98 shares in Q1 2026
Build-A-Bear Workshop (BBW)
93 shares in Q1 2026
Parker Hannifin (PH)
68 shares in Q1 2026
Halozyme (HALO)
62 shares in Q1 2026
LIVEPERSON INC
52 shares in Q1 2026
Abercrombie & Fitch (ANF)
47 shares in Q1 2026
ENTEGRIS INC · CALL
46 shares in Q1 2026
Acushnet Company (GOLF)
43 shares in Q1 2026
Iradimed (IRMD)
42 shares in Q1 2026
Clorox (CLX)
37 shares in Q1 2026
Alphabet (GOOGL) · CALL
36 shares in Q1 2026
Zoetis (ZTS)
34 shares in Q1 2026
SELECT SECTOR SPDR TR · PUT
25 shares in Q1 2026
PERPETUA RESOURCES CORP · CALL
25 shares in Q1 2026
